Preparation of and Drug Release from W/O/W Type Double Emulsions Containing Anticancer Agents
スポンサーリンク
概要
- 論文の詳細を見る
Water-in-oil-in-water (W/O/W) type double emulsions were prepared by two-step emulsification procedures. The structures of W/O/W type double emulsions and the release characteristics of cytarabine and 5-fluorouracil (5-FU) from W/O/W type double emulsions were studied. W/O/W type double emulsions were ruptured within 24h when sorbitan monooleate (SO-10) or sorbitan sesquioleate (SO-15) was used as a lipophilic emulsifier. On the other hand, W/O/W type double emulsions prepared in a hydrogenated castor oil (HCO-10) in peanut oil were still intact after 24h. Therefore, the release characteristics of drugs were studied in HCO-10 in peanut oil. The release of cytarabine from W/O/W type double emulsions was very prolonged. The release of cytarabine was enhanced with increase in the volume of inner aqueous phase or increase in the concentration of HCO-10. The concentration of cytarabine and the concentration of a hydrophilic emulsifier (HCO-60), however, had little effect on the release of cytarabine. Whereas the release of 5-FU from W/O/W type double emulsions was as fast as from a simple solution, the release was very prolonged when the pH value of the inner aqueous phase was adjusted to 10.0. These results show the utility of W/O/W type double emulsions for sustained release preparations and raise the possibility of control of drug release from W/O/W type double emulsions.
- 社団法人日本薬学会の論文
- 1983-11-25
著者
-
福島 昭二
神戸学院大学薬学部臨床薬剤学研究室
-
福島 昭二
Department Of Pharmacy Kumamoto University Hospital Faculty Of Pharmaceutical Sciences Kobe-gakuin U
-
従二 和彦
城西大・薬
-
従二 和彦
Faculty Of Pharmaceutical Sciences Josai University
-
Fukushima S
Department Of Pharmacy Kumamoto University Hospital
-
従二 和彦
Department of Pharmacy, Kumamoto University Hospital
-
中野 真汎
Department of Pharmacy, Kumamoto University Hospital
関連論文
- 肝細胞癌TACE治療薬の新展開--リピオドール高親和性プラチナ製剤の開発
- O3-009 サリドマイドのラセミ体および光学活性体のHPLC、LCMSによる血中濃度測定法の開発(一般演題 口頭発表,がん薬物療法,医療薬学の創る未来 科学と臨床の融合)
- Sustained Release of Sulfamethizole from Agar Beads after Oral Administration to Humans
- 01P2-143 血中エフェドリン濃度を指標とした葛根湯エキス製剤投与スケジュールの改善
- 薬学教育6年制の早期体験学習に関する学生へのアンケート調査とその解析
- 薬学教育6年制の早期体験学習の受け入れ施設へのアンケート調査とその解析
- 30P3-141 薬学6年制導入後の早期体験学習の実態調査と今後の課題 : 薬-薬-学連携を通じて学生へのアンケート調査より(薬学教育・生涯教育(認定),医療薬学の扉は開かれた)
- Microparticulate bombardment system を用いた抗原含有微粒子の免疫処置に関する研究
- P-188 兵庫県病院薬剤師会における専門薬剤師育成への取り組み : 電子メールによる専門薬剤師育成プログラムの導入
- 30P3-120 薬学6年制導入後の早期体験学習の実態調査と今後の課題 : 薬-薬-学連携を通じて受け入れ施設へのアンケート調査より(薬学教育・生涯教育(認定),医療薬学の扉は開かれた)
- 328 LiposomeΔ7-prostaglandinA_1のヌードマウス移植ヒト由来cisplatin耐性卵巣癌細胞への抗腫瘍効果と代謝機構
- 保険薬局および病院・診療所における学生実務実習の実態調査
- P-619 薬・薬・学連携をめざした勉強会(神戸薬学ネットワーク)の取り組み(19.薬学教育・生涯教育(認定),"薬剤師がつくる薬物治療"-薬・薬・学の連携-)
- 緑茶アミノ酸テアニンの組織分布とGlutamate Transporter介在性制癌剤効果増強
- Behavior of Propylene Glycol (PG) in Dermis after Treatment of Rat Intact Skin Surface with Fatty Acids, Fatty Amines or Azone Dissolved in PG
- Effects of Oleic Acid/Propylene Glycol on Rat Abdominal Stratum Corneum : Lipid Extraction and Appearance of Propylene Glycol in the Dermis Measured by Fourier Transform Infrared/Attenuated Total Reflectance (FT-IR/ATR) Spectroscopy
- Cancer Electrochemotherapy(癌電気化学療法)に関する研究(その13)低電圧電気パルスを併用した場合の抗腫瘍効果の検討
- Electroporation法とIontophoresisの併用によるインスリンの皮膚透過促進効果
- Diltiazem とAprindine の薬物相互作用(第2報) : ヒト肝ミクロゾームによる検討
- CDDP耐性肝癌株(H4-II-E/CDDP)におけるCDDPの細胞内取り込みの変化
- SM-11355/リピオドール懸濁液の作用機序 - 投与剤形における in vitro 細胞増殖制御効果と細胞内取りこみ挙動の評価 -
- 13P-7-39 C 型慢肝炎患者における血漿中グルタチオン濃度とインターフェロン治療効果との関連
- Cancer Electrochemotherapy (癌電気化学療法)に関する研究(その7) : ブレオマイシン投与を電気パルス負荷前あるいは負荷後に行った場合の増殖抑制効果の比較
- リポソーム中の脂質の過酸化に対するタウリンの抑制作用
- Protective Effects of Some Neutral Amino Acids against Hypotonic Hemolysis
- 難溶性薬物グリベンクラミドの溶出試験法
- 薬物皮膚適用後の皮内挙動解明のためのウサギ耳灌流法に関する基礎的研究
- Disposition of Enantiomers of sultopride in a Human, Rats and Rabbits
- 5種類の硝酸イソソルビド徐放性製剤の製剤評価
- 血中メキシレチン濃度測定における螢光偏光免疫測定法の評価
- 人工血液使用による無輸血手術の可能性
- Release Characteristics of a Free Polyunsaturated Fatty Acid from an Oily Lymphographic Agent
- 抗腫瘍性プロスタグランジンの作用メカニズム解明 : G1期での遺伝子制御
- Inhibition of 5'-Deoxy-5-fluorouridine Phosphorolysis by Acyclopyrimidinenucleosides in Intestinal Tissue Homogenates
- Differential Effects of Acyclothymidine, a Potent Pyrimidine Nucleoside Phosphorylase Inhibitor, on the Pharmacokinetics of Doxifluridine in Rabbits via Oral Administration
- 薬物血中濃度モニタリング患者における小児薬用量の解析
- II-B-4 マイトマイシン C の体内動態に対する十全大補湯の影響
- Studies on 2', 3'-Dideoxy-2', 3'-didehydropyrimidine Nucleosides. II. : N_4-Benzoyl-2', 3'-dideoxy-2', 3'-didehydrocytidine as a Prodrug of 2', 3'-Dideoxy-2', 3'-didehydrocytidine (DDCN)
- Enzymatic and Chemical Stability of 2', 3'-Dideoxy-2', 3'-didehydropyrimidine Nucleosides : Potential Anti-acquired Immunodeficiency Syndrome Agents
- マイクロスフィア, エマルジョンなどによる抗がん薬の効果, 増強 : 薬剤の有効な投与方法に関する研究
- 薬物注腸時の粘膜刺激性
- Preparation of and Drug Release from W/O/W Type Double Emulsions Containing Anticancer Agents
- Thymidineの鼻粘膜透過に関する研究
- 微粒子を用いたDDS
- 皮膚適用後のフルルビプロフェンの皮下移行性に関する研究
- 市販製剤品質比較試験法の基準の作成(病院薬局協議会)
- 市販製剤品質比較試験法の基準の作成(病院薬局協議会)
- 市販製剤品質比較試験法の基準の作成
- Prodrugs of 2', 3'-Dideoxyinosine (DDI) : Improved Oral Bioavailability via Hydrophobic Esters
- Sustained Release of Theophylline from Konjac Gels
- Analysis of Permeation Profiles of Drugs from Systems containing Micelles
- Controlled Release of Butamben (Buryl p-aminobenzoate) through Silicone Membrane by Means of Complexation and Micellar Solubilization
- Controlled Drug Permeation. II. Comparative Permeability and Stability of Butamben and Benzocaine
- Physical Properties of Pyrimidine and Purine Antimetabolites. I. The Effects of Salts and Temperature on the Solubility of 5-Fluorouracil, 1-(2-Tetrahydrofuryl)-5-fluorouracil, 6-Mercaptopurine, and Thioinosine
- 徐放性製剤 (医薬品の新しい製剤技術)
- 高分子を用いた薬物制御放出剤形
- Sustained Release of Sulfamethizole, 5-Fluorouracil, and Doxorubicin from Ethylcellulose-Polylactic Acid Microcapsules
- Mechanism of Enhancement of the Release Rate of Aclarubicin from Poly-β-hydroxybutyric Acid Microspheres by Fatty Acid Esters
- Modification of the Release Rate of Aclarubicin from Polylactic Acid Microspheres by Using Additives
- Control of Release Rate of Bleomycin from Polylactic Acid Microspheres by Additives
- Preparation and Evaluation in Vitro and in Vivo of Polylactic Acid Microspheres Containing Doxorubicin
- Preparation and Evaluation in Vitro and in Vivo of Polylactic Acid Microspheres containing Dibucaine
- Influence of Physicochemical Properties of Polylactic Acid on the Characteristics and in Vitro Release Patterns of Polylactic Acid Microspheres containing Local Anesthetics
- Preparation and Evaluation in Vitro of Polylactic Acid Microspheres Containing Local Anesthetics
- Identification of the Decomposition Products of Hydralazine Hydrazones with Three Endogenous Ketones and Kinetic Study of the Formation of 3-Methyl-s-triazolo [3,4-a] phthalazine from Hydralazine and Pyruvic Acid
- 原末変更に伴うジゴキシン製剤の生物学的同等性の検討
- Preparation and Evaluation in Vitro and in Vivo of Polycarbonate Microspheres Containing Dibucaine
- Preparation and Evaluation in Vitro of Polycarbonate Microspheres Containing Local Anesthetics
- ケノデオキシコール酸カプセル剤の品質比較試験
- セファドロキシルカプセル剤の溶出試験
- Plasma Levels of Tegafur Following Implantation of Polycarbonate Pellets Containing Tegafur or FD-1 into Rats
- Examination of Biodegradability of Poly (ethylene carbonate) and Poly (propylene carbonate) in the Peritoneal Cavity in Rats
- Release Profiles of 5-Fluorouracil and Its Derivatives from Polycarbonate Matrices in Vitro
- 土-P3-470 肝癌治療薬ミリプラチン製剤の加温およびエマルション化による物性変化(がん薬物療法(その他),ポスター発表,一般演題,再興、再考、創ろう最高の医療の未来)